Results 171 to 180 of about 331,825 (303)

Empowering Patients: The Role of Shared Treatment Decision-Making in Advanced Bladder Cancer-A Podcast. [PDF]

Adv Ther
Kanesvaran R, Giannatempo P, Filicevas A.   +2 more
europepmc   +1 more source

Addressing the hidden toxicities of cancer: a call to action for clinicians, researchers and clinical trialists

BMJ Oncology
Rick Bangs
doaj   +1 more source

Drug‐coated balloons: From conventional designs to next‐generation innovations in vascular therapy

BMEMat, EarlyView.
This review traces the evolution of drug‐coated balloons (DCBs) from conventional designs to next‐generation platforms. We highlight innovations in balloon engineering, coating technologies, and therapeutic agents that enhance localized drug delivery while addressing challenges in efficiency, safety, and biocompatibility for vascular and emerging non ...
Lu Zhang, Jiawei Cui, Jin Wang, Manfred F. Maitz, Rifang Luo, Yunbing Wang   +5 more
wiley   +1 more source

A five-gene mitochondria-associated prognostic signature for bladder cancer. [PDF]

Int J Clin Exp Pathol
Liu J, Li B, Hou R, Sun J, Ning X, Li C, Li F, Zhang L.   +7 more
europepmc   +1 more source

Remediation of Organic Pollutant for Wastewater Treatment by Employing Sustainable Graphene Oxide/NiO‐ZrO2/Zeolite Ternary Composite Material

CleanMat, EarlyView.
Graphene oxide/NiO‐ZrO2/zeolite ternary composite was synthesized hydrothermally. Efficient adsorption of Congo red onto GO/NiO‐ZrO2/zeolite composite was studied. ABSTRACT The present study employs a novel method for the synthesis of graphene oxide (GO) based ternary composite utilized for the adsorption of Congo red (CR), an anionic dye molecule. The
Hidaya Narzary, Nituraj Mushahary, Bipul Das, Sanjay Basumatary   +3 more
wiley   +1 more source

A new target: AlkBH2 promotes bladder cancer by upregulation of inflammation. [PDF]

PLoS One
Yang Z, Ma J, Qiang Z, Xie W, Jiao L, Chen G.   +5 more
europepmc   +1 more source

From Metabolic Crisis to Molecular Classification: Multidisciplinary Management of Synchronous Endometrioid Ovarian and Endometrial Carcinomas With Massive Tumor Burden

Cancer Nexus, EarlyView.
Managing massive tumor burden in synchronous endometrioid carcinomas. The graphical abstract summarizes the clinical pathway from presentation with massive ascites, pleural effusion, and critical metabolic abnormalities to multidisciplinary stabilization, surgical management, integrated morphologic–molecular classification, and shared decision‐making ...
Anna Homeniuk, Leena Abdalla, Sharon Fitzgerald   +2 more
wiley   +1 more source

Ferroptosis as a therapeutic vulnerability in ARID1A-deficient bladder cancer. [PDF]

Commun Biol
Zhao M, Wang X, Duan X, Wu C, Guo R, Wen Y, Liang J, Zhou J, Lei X, Fu S, Wang H, Peng C, Guo C.   +12 more
europepmc   +1 more source

Response to the Letter to the Editor Entitled “Revisiting Vincristine for FSGS: Proof-of-Mechanism Arrives, but Whom Should we Treat?”

Kidney International Reports
William J. Mason, Jennifer C. Chandler, Alice M. Gage, Gideon Pomeranz, Karen L. Price, Marilina Antonelou, Scott R. Henderson, Laura Perin, Stefano Da Sacco, Alan D. Salama, David A. Long, Ruth J. Pepper   +11 more
doaj   +1 more source

Flow cytometry‐based monitoring of chimeric antigen receptor (CAR) T cells: Reagent selection, assay design, and clinical utility

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract Accurate quantification of chimeric antigen receptor (CAR) T cells is essential for monitoring post‐infusion CART expansion and persistence and for real‐time clinical decision‐making. Multiparameter flow cytometry (MFC) enables rapid, live‐cell detection with absolute quantification and concurrent immunophenotypic characterization. This review
Jianhua Ling, Wei Wang, Sa A. Wang
wiley   +1 more source